Erratum: Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: The Suita study (Journal of Atherosclerosis and Thrombosis, (2014) 21, 8, (784-798), 10.5551/jat.19356);Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham risk score: The Suita study

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 8, 2014, Pages 784-798

  Nishimura, Kunihiro ^a   Okamura, Tomonori ^b   Watanabe, Makoto ^a   Nakai, Michikazu ^a   Takegami, Misa ^a   Higashiyama, Aya ^c   Kokubo, Yoshihiro ^a   Okayama, Akira ^d   Miyamoto, Yoshihiro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d FUKUJUJI HOSPITAL   (Japan)

Author keywords

Coronary heart disease; Framingham risk score; Japanese cohort; Risk score; Suita study

Indexed keywords

ACCURACY; ADULT; AGED; ALGORITHM; ANALYTICAL PARAMETERS; ARTICLE; CALIBRATION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; JAPANESE (PEOPLE); MALE; PREDICTION; RISK FACTOR; SCORING SYSTEM; SMOKING; SUITA SCORE; URBAN POPULATION; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY DISEASE; JAPAN; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

BIOLOGICAL MARKER;

ADULT; AGED; ALGORITHMS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; URBAN POPULATION;

EID: 84906811252     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.Er19356     Document Type: Erratum

References (57)

1. Dawber TR, Kannel WB, Revotskie N, Stokes J, 3rd, Kagan A, Gordon T: Some factors associated with the development of coronary heart disease: Six years’ follow-up experience in the framingham study. Am J Public Health Nations Health, 1959; 49: 1349-1356
2. Wilson PW, Castelli WP, Kannel WB: Coronary risk prediction in adults (the framingham heart study). Am J Cardiol, 1987; 59: 91G-94G
3. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB:, Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
4. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D: Prevention of coronary heart disease in clinical practice: Recommendations of the task force of the european society of cardiology, european atherosclerosis society and european society of hypertension. Atherosclerosis, 1994; 110: 121-161
5. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel ⅲ) final report. Circulation, 2002; 106: 3143-3421
6. D’Agostino RB, Sr., Grundy S, Sullivan LM, Wilson P: Validation of the framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA, 2001; 286: 180-187
7. Thomsen TF, McGee D, Davidsen M, Jorgensen T: A cross-validation of risk-scores for coronary heart disease mortality based on data from the glostrup population studies and framingham heart study. Int J Epidemiol, 2002; 31: 817-822
8. Hense HW, Schulte H, Lowel H, Assmann G, Keil U: Framingham risk function overestimates risk of coronary heart disease in men and women from germany--results from the monica augsburg and the procam cohorts. Eur Heart J, 2003; 24: 937-945
9. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T: Cardiovascular disease and risk factors in asia: A selected review. Circulation, 2008; 118: 2702-2709
10. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a japanese representative population. Circ J, 2006; 70: 1249-1255
11. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K: Executive summary of the japan atherosclerosis society (jas) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in japan -2012 version. J Atheroscler Thromb, 2013; 20: 517-523
12. Arima H, Yonemoto K, Doi Y, Ninomiya T, Hata J, Tanizaki Y, Fukuhara M, Matsumura K, Iida M, Kiyohara Y: Development and validation of a cardiovascular risk prediction model for japanese: The hisayama study. Hypertens Res, 2009; 32: 1119-1122
13. Noda H, Iso H, Sairenchi T, Irie F, Fukasawa N, Toriyama Y, Ota H, Nose T:, prediction of stroke, coronary heart disease, cardiovascular disease, cancer, and total death based on results of annual health checkups. Nippon Koshu Eisei Zasshi, 2006; 53: 265-276
14. Tanabe N, Iso H, Okada K, Nakamura Y, Harada A, Ohashi Y, Ando T, Ueshima H,Group. JALS: Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events - the jals-ecc. Circ J, 2010; 74: 1346-1356
15. Matsumoto M, Ishikawa S, Kayaba K, Gotoh T, Nago N, Tsutsumi A, Kajii E: Risk charts illustrating the 10-year risk of myocardial infarction among residents of japanese rural communities: The jms cohort study. J Epidemiol, 2009; 19: 94-100
16. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305
17. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol, 2004; 15: 1307-1315
18. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P: Predicting cardiovascular risk in england and wales: Prospective derivation and validation of qrisk2. BMJ (Clinical research ed.), 2008; 336: 1475-1482
19. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ: The framingham predictive instrument in chronic kidney disease. Journal of the American College of Cardiology, 2007; 50: 217-224
20. Kokubo Y, Nakamura S, Okamura T, Yoshimasa Y, Makino H, Watanabe M, Higashiyama A, Kamide K, Kawanishi K, Okayama A, Kawano Y: Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban japanese population with and without chronic kidney disease: The suita study. Stroke, 2009; 40: 2674-2679
21. Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A: Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban japanese population: The suita study. Circ J, 2009; 73: 2258-2263
22. Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, Okayama A, Tomoike H: Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban japanese population: The suita study. Hypertens Res, 2008; 31: 2027-2035
23. Kokubo Y, Kamide K, Okamura T, Watanabe M, Higashiyama A, Kawanishi K, Okayama A, Kawano Y: Impact of high-normal blood pressure on the risk of cardiovascular disease in a japanese urban cohort: The suita study. Hypertension, 2008; 52: 652-659
24. Watanabe M, Okamura T, Kokubo Y, Higashiyama A, Okayama A: Elevated serum creatine kinase predicts firstever myocardial infarction: A 12-year population-based cohort study in japan, the suita study. Int J Epidemiol, 2009; 38: 1571-1579
25. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Estimation of glomerular filtration rate by the mdrd study equation modified for japanese patients with chronic kidney disease. Clin Exp Nephrol, 2007; 11: 41-50
26. K/doqi clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis, 2002; 39: S1-S266
27. Monica manual. Cvd/mnc/version 1.1, 1986 dec. Geneva: WHO. 1987: 1-104 (S-104)
28. Cook NR: Statistical evaluation of prognostic versus diagnostic models: Beyond the roc curve. Clinical chemistry, 2008; 54: 17-23
29. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, Krestin GP, Oudkerk M, de Maat MP,Leebeek FW, Mattace-Raso FU, Lindemans J, Hofman A, Steyerberg EW, van der Lugt A, van den Meiracker AH,Witteman JC:, Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study. Ann Intern Med, 2012; 156: 438-444
30. Pencina MJ, D’Agostino RB, Sr., Steyerberg EW:, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med, 2011; 30: 11-21
31. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K: Diagnostic criteria for dyslipidemia. J Atheroscler Thromb, 2013; 20: 655-660
32. Tuomilehto J, Kuulasmaa K: Who monica project: Assessing chd mortality and morbidity. Int J Epidemiol, 1989; 18: S38-S45
33. Keil U, Kuulasmaa K: Who monica project: Risk factors. Int J Epidemiol, 1989; 18: S46-S55
34. Liu J, Hong Y, D’Agostino RB, Sr., Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D:, Predictive value for the chinese population of the framingham chd risk assessment tool compared with the chinese multi-provincial cohort study. JAMA, 2004; 291: 2591-2599
35. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, et al.: Serum total cholesterol and longterm coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA, 1995; 274: 131-136
36. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int, 1999; 56: 2214-2219
37. Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, Salem DN, Levey AS, Sarnak MJ: Cardiovascular outcomes and all-cause mortality: Exploring the interaction between ckd and cardiovascular disease. Am J Kidney Dis, 2006; 48: 392-401
38. Weiner DE, Tighiouart H, Griffith JL, Elsayed E, Levey AS, Salem DN, Sarnak MJ: Kidney disease, framingham risk scores, and cardiac and mortality outcomes. Am J Med, 2007; 120: 552 e551-e558
39. Higashiyama A, Watanabe M, Kokubo Y, Ono Y, Okayama A, Okamura T: Relationships between protein intake and renal function in a japanese general population: Nippon data90. J Epidemiol, 2010; 20 Suppl 3 : S537-S543
40. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Jr., Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O’Donnell CJ, Smith SC, Jr., Wilson PW:, Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the american heart association. Circulation, 2009; 119: 2408-2416
41. Duprez DA, Jacobs DR, Jr., Lutsey PL, Bluemke DA, Brumback LC, Polak JF, Peralta CA, Greenland P, Kronmal RA: Association of small artery elasticity with incident cardiovascular disease in older adults: The multi-ethnic study of atherosclerosis. Am J Epidemiol, 2011; 174: 528-536
42. Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S, Afonso L: Homocysteine and reclassification of cardiovascular disease risk. Journal of the American College of Cardiology, 2011; 58: 1025-1033
43. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D’Agostino RB, Vasan RS:, Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med, 2006; 355: 2631-2639
44. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol, 2004; 159: 882-890
45. Ware JH: The limitations of risk factors as prognostic tools. N Engl J Med, 2006; 355: 2615-2617
46. Eddy DM, Adler J, Patterson B, Lucas D, Smith KA, Morris M: Individualized guidelines: The potential for increasing quality and reducing costs. Ann Intern Med, 2011; 154: 627-634
47. Nephrology JSo: Guideline of ckd diagnosis and treatment 2009; 2012
48. Kanemoto Y KR: Urban employment areas: Defining japanese metropolitan areas and constructing the statistical database for them. CRC Taylor & Francis; 2006
49. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K, Absolute risk of cardiovascular disease and lipid management targets. Journal of atherosclerosis and thrombosis,, 2013
50. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban japanese cohort study: The suita study. Atherosclerosis, 2009; 203: 587-592
51. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observa tional studies corrected for the regression dilution bias. Lancet, 1990; 335: 765-774
52. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H: Trend of westernization of etiology and clinical characteristics of heart failure patients in japan--first report from the chart-2 study. Circ J, 2011; 75: 823-833
53. Nagasawa S-y, Okamura T, Iso H, Tamakoshi A, Yamada M, Watanabe M, Murakami Y, Miura K, Ueshima H,, Group ftEfCPfOCiJR: Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: A pooled analysis of 65 594 individuals from 10 cohort studies in japan. Journal of the American Heart Association, 2012; 1
54. Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, LloydJones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Jr., Watson K, Wilson PW: 2013 acc/aha guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the american college of cardiology/american heart association task force on practice guidelines. Circulation, 2013
55. Hasokawa M, Shinohara M, Tsugawa H, Bamba T, Fukusaki E, Nishiumi S, Nishimura K, Yoshida M, Ishida T, Hirata K: Identification of biomarkers of stent restenosis with serum metabolomic profiling using gas chromatography/mass spectrometry. Circ J, 2012; 76: 1864-1873
56. Saito I, Kokubo Y, Kiyohara Y, Doi Y, Saitoh S, Ohnishi H, Miyamoto Y: Prospective study on waist circumference and risk of all-cause and cardiovascular mortality. Circ J, 2012; 76: 2867-2874
57. Nakajima K, Matsuo S, Okuyama C, Hatta T, Tsukamoto K, Nishimura S, Yamashina A, Kusuoka H, Nishimura T: Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease. Circ J, 2012; 76: 168-175